Dr. Violet Zahedi is Creating Systems That Help World-Changing Ideas Thrive

Physician-entrepreneur Dr. Violet Zahedi has built a unique career in medicine, technology, and venture creation. Her newest endeavor, Xivius, represents the many years she spent navigating science-driven innovation and the challenges that prevent breakthrough ideas from becoming real-world solutions.

Xivius is a fully integrated venture and investment ecosystem that connects founders with the infrastructure and capital networks needed to bring their ideas to life. Unlike traditional accelerators or venture firms, Xivius operates as a system-driven model, aligning key players within a single framework to streamline ideas from conception to commercialization. For Dr. Zahedi, Xivius is the product of lived experience. Over the years, she has seen incredible ideas falter because they lacked just one critical component. Sometimes it was capital, while other times it was infrastructure or expert guidance. Xivius helps to close those gaps and create conditions where world-changing ideas can really thrive.

Born and raised in Gorgan, Iran, Dr. Zahedi was drawn to medicine by a desire to solve practical problems for patients. Her international experiences gave her a rare understanding of how medicine, science, and policy intertwine. She observed how regulatory structures, economic conditions, and institutional barriers often determine whether innovation succeeds or stalls. And in 2023, Dr. Zahedi founded Synamics Therapeutics in Denmark, her formal entry into the world of biotech entrepreneurship. Synamics set out with a goal to use artificial intelligence to predict the progression of cancer and design treatments tailored to those changes. Now headquartered in Los Angeles, Synamics uses AI to address one of humanity’s most complex diseases. Within its first year, the company achieved what fewer than one percent of startups accomplish, securing funding at the concept stage, which validated both its scientific and commercial potential. Synamics soon began forming partnerships with major cancer research centers in the United States, expanding its reach.

While leading Synamics through its early success, Dr. Zahedi encountered the recurring challenge that would ultimately inspire Xivius: the separation of expertise, capital, and infrastructure. Groundbreaking science is fragile and needs the right ecosystem around it to survive. Without that, even the most promising discoveries can fade into obscurity. This conviction became the foundation for Xivius, a venture that reimagines how innovation ecosystems function. Moreover, Xivius is a platform that connects founders, investors, and industry experts within one shared, intelligent infrastructure. These elements work in harmony, allowing ideas to move more easily from concept to market. The company offers operational infrastructure, access to expert networks, and pathways to aligned capital, ensuring that each venture it supports has the resources and insight needed for sustainable growth.

What makes Xivius different from other companies is its system-driven model. Whereas accelerators tend to be curriculum-bound and time-limited, and venture firms are primarily capital-driven, Xivius is designed to be continuous and self-sustaining. Its proprietary screening system uses AI and machine learning to align founders with the right investors and mentors, learning and improving with every interaction. The goal, Dr. Zahedi explains, is to make data-informed decisions rather than relying solely on intuition or precedent. “Founders remain at the nucleus of Xivius,” she says. “In short, Xivius exists to empower founders to lead boldly, with systems that make their risks smarter, their execution faster, and their vision stronger.” Xivius’ long-term goal is to enable high-potential ventures across sectors, from life sciences to emerging technologies. This will help people to access the right resources regardless of geography.

As Xivius prepares to launch globally, Dr. Zahedi sees it as a shift from isolated ambition to collaborative infrastructure. In this way, Dr. Violet Zahedi is part of a new generation of physician-entrepreneurs and leaders who are closing the divide between science and enterprise. Her ventures, Synamics and Xivius, are united by a shared idea that progress is about building the systems that allow invention to endure.

By Olivia Nerpouni